Priority Research Area Infections

Evolution of the Resistome

Mission    Projects    Funding    Techniques    Publications    Staff

Prof. Dr. Matthias Merker
Prof. Dr. Matthias Merker
04537 / 188-7570
04537 / 188-3110
This email address is being protected from spambots. You need JavaScript enabled to view it.


The global rise of antimicrobial resistance (AMR) is a public health crisis. The human microbiome and all associated resistance genes ("the resistome") are under constant evolutionary pressure. Disease, treatment, microbiome cross-talk, and the host immune system can change the composition of host microbes ("dysbiosis") or select for antimicrobial resistances. We employ laboratory evolution experiments and microbial genomics, such as whole (meta)genome sequencing, to understand bacterial evolutionary pathways that influence disease progression or treatment outcomes. In the long run, we seek to identify improved therapies which reduce or prevent pathogen adaptation, e.g. resistance evolution, and preserve a healthy microbiome.